-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

653.O3.6 653. Myeloma/Amyloidosis: Therapy, excluding Transplantation: Relapsed/Refractory Multiple Myeloma

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
therapy sequence, multiple myeloma, Adult, AML, antibodies, apoptosis, Biological, smoldering myeloma, Diseases, CML, Non-Biological, Therapies, Combinations, CMML, Adverse Events, chemotherapy, MDS, Biological Processes, MPN, immunotherapy, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies
Sunday, December 6, 2020: 12:00 PM-1:30 PM
Moderators:
Attaya Suvannasankha, MD, Indiana University School of Medicine and Joshua Richter, M.D., Icahn School of Medicine at Mount Sinai
Disclosures:
No relevant conflicts of interest to declare.
12:00 PM

Meletios A. Dimopoulos, MD1, Evangelos Terpos, MD, PhD1, Mario Boccadoro2, Sosana Delimpasi, MD3*, Meral Beksac, MD4, Eirini Katodritou, MD5*, Philippe Moreau, MD6*, Luca Baldini, MD, PhD7*, Argiris Symeonidis, MD, PhD8, Jelena Bila9*, Albert Oriol10*, Maria-Victoria Mateos, MD, PhD11, Hermann Einsele, MD12, Ioannis Orfanidis13*, Tahamtan Ahmadi, MD, PhD14*, Jon Ukropec, PhD15, Tobias Kampfenkel, MD16, Jordan Schecter17*, Yanping Qiu18*, Himal Amin17*, Jessica Vermeulen, MD, PhD16*, Robin Carson, MD, BA19 and Pieter Sonneveld, MD, PhD20

1National and Kapodistrian University of Athens, Athens, Greece
2University of Torino, Turin, Italy
3Evangelismos Hospital, Athens, Greece
4Ankara University, Ankara, Turkey
5Theagenio Cancer Hospital, Thessaloniki, Greece
6Hematology, University Hospital Hôtel-Dieu, Nantes, France
7University of Milan, Milan, Italy
8Hematology Division, Department of Internal Medicine, University of Patras, Medical School, Patras, Greece
9University of Belgrade, Belgrade, Serbia
10Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias I Pujol, Barcelona, Spain
11University Hospital of Salamanca/IBSAL/Cancer Research Center- IBMCC (USAL-CSIC), Salamanca, Spain
12Würzburg University Medical Centre, Würzburg, Germany
13Health Data Specialists S.A., Dublin, Ireland
14Genmab US, Inc, Princeton, NJ
15Janssen Global Medical Affairs, Horsham, PA
16Janssen Research & Development, LLC, Leiden, Netherlands
17Janssen Research & Development, LLC, Raritan, NJ
18Janssen Research & Development, Beijing, China
19Janssen Research & Development, LLC, Spring House, PA
20Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands

12:15 PM

Michael Sebag, MD, PhD1, Nizar Bahlis, MD2, Christopher P. Venner, MD3, Arleigh McCurdy, MD, BSc4, C. Tom Kouroukis, MD, MSc, FRCPC5, Jesse Shustik, MD6, Rami Kotb, MD7*, Darrell J White, MD8, Julie Stakiw, MD9, Nicole B. Laferriere, MD, PhD10,11, Anthony Reiman, MD12*, Fernando Camacho, PhD13*, Molei Fu13*, Engin Gul, BSc14* and Donna E. Reece, MD15,16

1Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
2Tom Baker Cancer Center, University of Calgary, Calgary, AB, Canada
3Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
4Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
5Juravinski Cancer Centre, Hamilton, ON, Canada
6BC Cancer Agency, Surrey, BC, CAN
7Cancer Care Manitoba, Winnipeg, MB, Canada
8Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
9Saskatoon Cancer Centre, Saskatoon, SK, Canada
10NWORCC, Thunder Bay, ON, CAN
11Thunder Bay Regional Health Sciences, Thunder Bay, ON, Canada
12University of New Brunswick, Saint John Regional Hospital, Saint John, NB, CAN
13Canadian Myeloma Research Group (formerly MCRN), Vaughan, ON, Canada
14University Health Network-PMH, Concord, ON, Canada
15Canadian Myeloma Research Group (formerly MCRN), Toronto, Canada
16Princess Margaret Cancer Centre, Toronto, ON, Canada

12:30 PM

Thomas Martin, MD1, Joseph Mikhael, MD, FRCPC, MEd2, Roman Hajek, MD3, Kihyun Kim, MD, PhD4, Kenshi Suzuki, MD, PhD5, Cyrille Hulin, MD6*, Mamta Garg, MD, FRCP, FRCPath7*, Hang Quach, MD, FRACP, FRCPA, MBBS8, Hanlon Sia9*, Anup George10*, Tatiana Konstantinova, MD, PhD11*, Marie-Laure Risse12*, Gaelle Asset13*, Sandrine Macé12*, Helgi van de Velde, MD, PhD14 and Philippe Moreau15*

1Department of Medicine, University of California, San Francisco, CA
2Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ
3Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic
4Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
5Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan
6Department of Hematology, University Hospital Bordeaux, Bordeaux, France
7Department of Haematology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
8Department of Haematology, St. Vincent's Hospital, Melbourne, Australia
9Cancer Care & Haematology Unit, The Tweed Hospital, Tweed Heads, NSW, Australia
10Wellington Blood and Cancer Center, Wellington, New Zealand
11Hematology Department, Regional Clinical Hospital №1, Ekaterinburg, Russian Federation
12Sanofi Research and Development, Vitry-Sur-Seine, France
13Sanofi R&D, Chilly-Mazarin, France
14Sanofi, Cambridge, MA
15Department of Hematology, University Hospital of Nantes, Nantes, France

12:45 PM

Maria-Victoria Mateos, MD, PhD1, Enrique M. Ocio, MD, PhD2, Anna Sureda Balari, MD, PhD3*, Albert Oriol4*, Esther González Garcia, MD5*, Maria José Moreno6*, Miquel Granell, MD7*, Fernando Escalante, MD8*, Veronica Gonzalez De La Calle, MD, PhD9*, Laura Rosinol, MD, PhD10*, Estrella Carrillo-Cruz, MD11*, Joaquín Martínez-López12*, Maria Victoria Dourdil Sahun13*, Marta Sonia Gonzalez, MD14*, Jaime Perez De Oteyza, MD, PhD15, Felipe De Arriba, PhD16*, Miguel T Hernández, MD, PhD17*, Aránzazu García Mateo, PhD18*, Ana Pilar Gonzalez, PhD19*, Rafael Rios, MD, PhD20*, Carmen Cabrera21*, Juan Jose Bargay22*, Paula Rodriguez-Otero, MD23*, Felipe Casado24*, Maria Casanova, MD25*, María Jesús Blanchard26*, Joan Blade Creixenti27, Juan Jose Lahuerta, MD, PhD28* and Jesus F. San-Miguel, MD, PhD29

1Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain
2Hematology Department, Hospital Universitario De Salamanca, Santander, Spain
3Institut Català d'Oncologia-Hospital Duran i Reynals, Hospitalet del Llobregat, Spain
4HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL DE BADALONA, Badalona, Barcelona, ESP
5Hospital de Cabueñes, Gijón, Spain
6Hospital Virgen de la Arrixaca de Murcia, murcia, Spain
7Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
8Department of Hematology, Hospital Universitario de Leon, Leon, Spain
9Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), Salamanca, Spain
10University of Barcelona, Barcelona, Spain
11Hematology Department, Hospital Vírgen del Rocío, Seville, Spain
12Hematology and hemotherapy department, Hospital Universitario 12 De Octubre, Madrid, Spain
13Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain
14Hospital Universitario de Santiago, Santiago de Compostela, Spain
15Hospital Universitario Madrid Sanchinarro, Madrid, Spain
16Hospital Morales Meseguer, Murcia, Spain
17Department of Hematology, Hospital Universitario de Canarias, La Laguna, Spain
18Hospital General de Segovia, Segovia, Spain
19Hospital Central de Asturias, Oviedo, Spain
20Servicio de Hematología y Hemoterapia, Hospital Universitario Virgen de las Nieves, Granada, Spain
21Hospital San Pedro de Alcantara, Caceres, Spain
22Hospital son LLatzer, Palma de Mallorca, ESP
23Clínica Universidad de Navarra-Pamplona, Pamplona, Spain
24Complejo Hospitalario de Toledo, Toledo, Spain
25Hematology Department, Hospital Costa del Sol Marbella, Marbella, Spain
26Hospital Ramón y Cajal, Madrid, Spain
27Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain
28Hospital Doce de Octubre, CIBERONC, Madrid, Spain
29Hematology Department, Clínica Universidad De Navarra, Pamplona, Spain

1:00 PM

Wenming Chen, MD1*, Zhongjun Xia, MD, PhD2, Baijun Fang3*, Chengcheng Fu4*, Wei Li, MD5*, Linhua Yang6*, Xiao-yan Ke7*, Hua Jiang, MD8*, Jianyu Weng9*, Li Liu, MD10*, Yaozhong Zhao11*, Xuejun Zhang12*, Aichun Liu, MD13*, Zhongxia Huang14*, Qingzhi Shi15*, Yuhuan Gao16*, Xiequn Chen17*, Ling Pan, MD, PhD18*, Zhen Cai, MD, PhD19*, Zhao Wang, MD20*, Yafei Wang21*, Yaqun Fan22*, Ming Hou23, Yigai Ma24*, Jianda Hu, MD, PhD25, Jianfeng Zhou, MD, PhD26*, Jing Liu, MD, PhD27*, Xiaohong Zhang28*, Haitao Meng, MD, PhD29*, Xuzhang Lu, PhD30*, Bintao Huang31*, Li Fei32, Hanyun Ren, MD33, Zonghong Shao, PhD34, Hebing Zhou35*, Yu Hu, MD36* and Shifang Yang, PhD37

1Department of Hematology, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China
2Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
3Department of Hematology, Henan Cancer Hospital,Henan Cancer Hospital Affiliated to Zhengzhou University, Zhengzhou, China
4Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China
5Department of Hematology, The First Hospital of Jilin University, Changchun, China
6Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China
7Department of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, China
8Department of Hematology, Chang Zheng Hospital,Second Military Medical University, Shanghai, China
9Department of Hematology, Guangdong General Hospital,Guangdong Academy of Medical Sciences, Guangzhou, China
10Tangdu Hospital, Air Force Medical University, Xi'an, China
11Department of Lymphoma Center, Institute of Hematology and Blood Diseases Hospital,Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China
12Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, China
13Department of Hematology and Lymphology, Harbin Medical University Cancer Hospital, Harbin, China
14Department of Hematology, Beijing Chao-yang Hospital,Capital Medical University, Beijing, China
15Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, China
16Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
17Department of Hematology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
18Department of Hematology, West China Hospital,Sichuan University, Chengdu, China
19Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
20Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
21Department of Hematology, Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
22Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, Medical College of Xiamen University, Xiamen, China
23Department of Hematology, Qilu Hospital, Shandong University, Jinan, China
24Departmentof Hematology, China-Japan Friendship Hospital, Beijing, China
25Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou, China
26Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
27Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, China
28Department of Hematology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
29Department of Hematology, The First Affiliated Hospital,School of Medicine,Zhejiang University, Hangzhou, China
30Department of Hematology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, China
31Department of Hematology, The Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia, China
32the First Affiliated Hospital of Nanchang University, Nanchang, China
33Department of Hematology, Peking University First Hospital, Beijing, China
34Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
35Department of Hematology, Beijing Luhe Hospital,Capital Medical University, Beijing, China
36Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
37Beijing Sunbio Biotech Co., Ltd., Beijing, China

1:15 PM

Enrique M. Ocio, MD, PhD1, Yvonne A. Efebera, MD, MPH2, Roman Hájek, MD, PhD3, Miquel Granell, MD4*, Vladimir Maisnar, MD5*, Jan Straub, MD6*, Jean-Richard Eveillard, MD7*, Lionel Karlin, MD8*, Vincent Ribrag, MD9, María-Victoria Mateos, MD, PhD10, Albert Oriol11*, Malin Sydvander, MSc12*, Stefan Norin, MD12*, Sofia Mannikko, MSc12* and Luděk Pour, MD13*

1University Hospital Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain
2Division of Hematology, The Ohio State University, Columbus, OH
3Department of Hemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic
4Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
5Fourth Department of Medicine - Hematology, FN and LF UK Hradec Králové, Hradec Králové, Czech Republic
6Všeobecná fakultní nemocnice, Prague, Czech Republic
7Hôpital A. Morvan, Centre Hospitalier Universitaire de Brest, Brest, France
8Department of Hematology, Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1, Pierre-Benite, France
9DITEP, Gustave Roussy, Université Paris-Saclay, Villejuif, France
10Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain
11Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
12Oncopeptides AB, Stockholm, Sweden
13Fakultní nemocnice Brno, Brno, Czech Republic

*signifies non-member of ASH